Synbiotics, probiotics or prebiotics in infant formula for full term infants: a systematic review

Nutrition Journal
Q1
Oct 2012
Citations:158
Influential Citations:8
Systematic Reviews / Meta-Analyses
88
S2 IconPDF Icon

Enhanced Details

Methods
Design: randomized controlled trials; participants: healthy full-term infants (>37 weeks gestation or birth weight ≥2.5 kg), age 0–12 months, formula-fed only; no disease, congenital abnormality or eczema; settings include multi-centre and single-centre trials; blinding described in some trials.
Intervention
Synbiotics: three regimens in term infant formulas. Regimen 1: Bifidobacterium longum BL999 + Lactobacillus rhamnosus; 90% galactooligosaccharide (GOS) + 10% short-chain fructooligosaccharide (scFOS); 0.4 g/100 mL; B. longum BL999 dose 1.29×10^8 to 2.58×10^8 CFU/100 mL; L. rhamnosus 6.45×10^8 CFU/100 mL; duration 4–6 months. Regimen 2: Bifidobacterium longum BL999 + Lactobacillus paracasei; 90% GOS + 10% scFOS; 0.4 g/100 mL; BL999 dose similar; duration 4–6 months. Regimen 3: Bifidobacterium longum BL999 alone; 90% GOS + 10% scFOS; 0.4 g/100 mL; duration 4–6 months. Probiotics: regimens used various strains (e.g., Bifidobacterium lactis Bb12; Lactobacillus GG; Lactobacillus reuteri; Bifidobacterium bifidum); dosages ranged from 1.5×10^6 to 3.85×10^8 CFU/g powder for Bifidobacteria and 1×10^6 to 1×10^8 CFU/g powder for Lactobacilli; durations from 14 days to 7 months; some formulas were acidified or reduced-protein.
Results
Synbiotics did not significantly improve growth (weight, length, head circumference). Probiotics did not significantly improve growth or (consistently) reduce infections; stool frequency may increase with some regimens, but results are inconsistent. Prebiotics increased weight gain modestly (approx. 0.97 g/day in meta-analysis) and stool frequency, but did not consistently affect length, head circumference, infections, or hospitalization. No evidence that synbiotics are superior to probiotics or prebiotics. Overall, evidence quality is low due to imprecision, inconsistency, varied preparations, and potential publication bias. Routine supplementation of term infant formula with synbiotics, probiotics or prebiotics is not supported.
Limitations
Small sample sizes in several studies; heterogeneity in strains/doses/durations; varied formulas and outcome reporting; risk of bias and potential publication bias; overall low certainty of evidence.

Abstract

BackgroundSynbiotics, probiotics or prebiotics are being added to infant formula to promote growth and development in infants. Previous reviews (2007 to 2011) on term infants given probiotics or prebiotics focused on prevention of allergic disease an...